STAT3 and STAT5a Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer

被引：0
|
作者：
Mohanty, S. K. [1 ]
Yagiz, K. [1 ]
Cinar, B. [1 ]
Amin, M. B. [1 ]
Luthringer, D. [1 ]
Alkan, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1849
引用
收藏
页码：444A / 444A
页数：1
相关论文
共 50 条
  • [1] STAT3 and STAT5a Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer
    Mohanty, S. K.
    Yagiz, K.
    Cinar, B.
    Amin, M. B.
    Luthringer, D.
    Alkan, S.
    LABORATORY INVESTIGATION, 2013, 93 : 444A - 444A
  • [2] STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer
    Mohanty, Sambit K.
    Yagiz, Kader
    Pradhan, Dinesh
    Luthringer, Daniel J.
    Amin, Mahul B.
    Alkan, Serhan
    Cinar, Bekir
    ONCOTARGET, 2017, 8 (49) : 85997 - 86010
  • [3] STAT3 and STAT5a are potential therapeutic targets in castration-resistant prostate cancer
    Mohanty, Sambit K.
    Yagiz, Kader
    Luthringer, Luthringer
    Amin, Mahul B.
    Alkan, Serhan
    Cinar, Bekir
    CANCER RESEARCH, 2017, 77
  • [4] Targeting STAT3 in castration-resistant prostate cancer: Galiellalactone as a direct inhibitor of STAT3 in prostate cancer cells.
    Hellsten, Rebecka
    Don-Doncow, Nicholas
    Escobar, Zilma
    Johansson, Martin Hans
    Kjellstrom, Sven
    Garcia, Victor
    Munoz, Eduardo
    Sterner, Olov
    Bjartell, Anders
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Hypoxic Tumor Kinase Signaling Mediated by STAT5A in Development of Castration-Resistant Prostate Cancer
    Roe, Kathrine
    Bratland, Ase
    Vlatkovic, Ljiljana
    Ragnum, Harald Bull
    Saelen, Marie Gron
    Olsen, Dag Rune
    Marignol, Laure
    Ree, Anne Hansen
    PLOS ONE, 2013, 8 (05):
  • [6] MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis
    Junqing Gan
    Shan Liu
    Yu Zhang
    Liangzi He
    Lu Bai
    Ran Liao
    Juan Zhao
    Madi Guo
    Wei Jiang
    Jiade Li
    Qi Li
    Guannan Mu
    Yangjiazi Wu
    Xinling Wang
    Xingli Zhang
    Dan Zhou
    Huimin Lv
    Zhengfeng Wang
    Yanqiao Zhang
    Cheng Qian
    MeiYan Feng
    Hui Chen
    Qingwei Meng
    Xiaoyi Huang
    Experimental & Molecular Medicine, 2022, 54 : 1290 - 1305
  • [7] STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
    Laudisi, Federica
    Cherubini, Fabio
    Monteleone, Giovanni
    Stolfi, Carmine
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06):
  • [8] MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis
    Gan, Junqing
    Liu, Shan
    Zhang, Yu
    He, Liangzi
    Bai, Lu
    Liao, Ran
    Zhao, Juan
    Guo, Madi
    Jiang, Wei
    Li, Jiade
    Li, Qi
    Mu, Guannan
    Wu, Yangjiazi
    Wang, Xinling
    Zhang, Xingli
    Zhou, Dan
    Lv, Huimin
    Wang, Zhengfeng
    Zhang, Yanqiao
    Qian, Cheng
    Feng, MeiYan
    Chen, Hui
    Meng, Qingwei
    Huang, Xiaoyi
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2022, 54 (08): : 1290 - 1305
  • [9] Androgen Receptor Cofactors in Prostate Cancer: Potential Therapeutic Targets of Castration-Resistant Prostate Cancer
    Shiota, Masaki
    Yokomizo, Akira
    Fujimoto, Naohiro
    Naito, Seiji
    CURRENT CANCER DRUG TARGETS, 2011, 11 (07): : 870 - 881
  • [10] Castration-resistant prostate cancer: potential targets and therapies
    Parray, Aijaz
    Siddique, Hifzur R.
    Nanda, Sanjeev
    Konety, Badrinath R.
    Saleem, Mohammad
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 267 - 276
12345